The confirmation of the appropriate BZD was viewed as accomplished if all the peaks found within the reference sample had been also witnessed in the drug sample with the correct amount of protons for every peak (Supplementary Products Appendix S4). Soon after integrating drug sample spectra, any peaks with a considerable integral benefit (>ten) wer